Browse Categories
| Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: A randomized trial - Abstract |
|
|
Last Updated ( Mon, 21 November 2011 )
Login to read more...| Male accessory gland infection frequency in infertile patients with chronic microbial prostatitis and irritable bowel syndrome - Abstract |
|
|
Last Updated ( Sun, 20 November 2011 )
Login to read more...| Effect of sexually transmitted infections, lifetime sexual partner count, and recreational drug use on lower urinary tract symptoms in men who have sex with men - Abstract |
|
|
Last Updated ( Fri, 28 October 2011 )
Login to read more...Last Updated ( Sat, 22 October 2011 )
Login to read more...| Beyond the Abstract - Uropathogenic Escherichia coli induces chronic pelvic pain, by Praveen Thumbikat, PhD, et al. |
|
|
Last Updated ( Fri, 21 October 2011 )
Login to read more...| Rising incidence of acute prostatitis following prostate biopsy: Fluoroquinolone resistance and exposure is a significant risk factor - Abstract |
|
|
Last Updated ( Fri, 14 October 2011 )
Login to read more...| Beyond the Abstract - Prevalence and risk factors for quinolone resistance among Escherichia coli strains isolated from males with community febrile urinary tract infection, by Alex Smithson, PhD |
|
|
Last Updated ( Tue, 11 October 2011 )
Login to read more...| FDA approves Cialis to treat benign prostatic hyperplasia |
|
|
Last Updated ( Mon, 10 October 2011 )
Login to read more...| Self Management Activation Randomised Trial for Prostatitis - (SMART-P): Study protocol for a randomised controlled trial - Abstract |
|
|
Last Updated ( Wed, 05 October 2011 )
Login to read more...| Treatment of benign prostatic hyperplasia by Prostiva(®): About a series of 76 cases - Abstract |
|
|
Last Updated ( Thu, 22 September 2011 )
Login to read more...Subscribe
Editors Corner
Featured Conference
Upcoming Conference
GU Cancers Symposium 2012
February 2 - 4, 2012
San Francisco Marriott Marquis
San Francisco, CA USA
Prostate cancer session highlights sponsored by Bristol-Myers Squibb


